These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8804994)

  • 1. Impaired interleukin-3 mRNA decay in autocrine mast cell tumors after transient calcium ionophore stimulation.
    Hirsch HH; Backenstoss V; Moroni C
    Growth Factors; 1996; 13(1-2):99-110. PubMed ID: 8804994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-3 mRNA stabilization by a trans-acting mechanism in autocrine tumors lacking interleukin-3 gene rearrangements.
    Hirsch HH; Nair AP; Backenstoss V; Moroni C
    J Biol Chem; 1995 Sep; 270(35):20629-35. PubMed ID: 7657642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
    Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
    Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene.
    Hirsch HH; Nair AP; Moroni C
    J Exp Med; 1993 Aug; 178(2):403-11. PubMed ID: 8340751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions.
    Wodnar-Filipowicz A; Moroni C
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):777-81. PubMed ID: 2105489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells.
    Ming XF; Kaiser M; Moroni C
    EMBO J; 1998 Oct; 17(20):6039-48. PubMed ID: 9774347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity.
    Nair AP; Hirsch HH; Moroni C
    Oncogene; 1992 Oct; 7(10):1963-72. PubMed ID: 1408138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line.
    Buckley MG; Williams CM; Thompson J; Pryor P; Ray K; Butterfield JH; Coleman JW
    Immunology; 1995 Mar; 84(3):410-5. PubMed ID: 7751024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay.
    Stoecklin G; Hahn S; Moroni C
    J Biol Chem; 1994 Nov; 269(46):28591-7. PubMed ID: 7961806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.
    Diamantis ID; Nair AP; Hirsch HH; Moroni C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9299-302. PubMed ID: 2512578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of calcium in the transcriptional and posttranscriptional regulation of the gonadotropin-releasing hormone gene in GT1-7 cells.
    Sun Y; Gore AC; Roberts JL
    Endocrinology; 1998 Jun; 139(6):2685-91. PubMed ID: 9607773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-dependent and oncogenic IL-3 mRNA stabilization can be distinguished pharmacologically and by sequence requirements in the 3'UTR.
    Wyss A; Moroni C
    Growth Factors; 2000; 18(2):109-18. PubMed ID: 11019782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transcriptional stabilization by interleukin-1beta of interleukin-6 mRNA induced by c-kit ligand and interleukin-10 in mouse bone marrow-derived mast cells.
    Lu-Kuo JM; Austen KF; Katz HR
    J Biol Chem; 1996 Sep; 271(36):22169-74. PubMed ID: 8703029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
    Pesch J; Brehm U; Staib C; Grummt F
    J Interferon Cytokine Res; 1996 Aug; 16(8):595-600. PubMed ID: 8877730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium and calcium ionophores on prolactin gene expression in GH3 and 235-1 rat pituitary tumor cells.
    Delidow BC; Lail-Trecker M; White BA
    Mol Endocrinol; 1992 Aug; 6(8):1268-76. PubMed ID: 1406704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras oncogenes amplify lymphokine (interleukin 3, granulocyte-macrophage colony-stimulating factor) induction by calcium ionophore.
    Hahn S; Wodnar-Filipowicz A; Nair AP; Moroni C
    Oncogene; 1991 Dec; 6(12):2327-32. PubMed ID: 1722572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for oncogenic regulators in an autocrine tumor model using differential display PCR: identification of novel candidate genes including the calcium channel mtrp6.
    Buess M; Engler O; Hirsch HH; Moroni C
    Oncogene; 1999 Feb; 18(7):1487-94. PubMed ID: 10050885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium signaling and protein kinase C for TNF-alpha secretion in a rat mast cell line.
    Nakata Y; Hide I
    Life Sci; 1998; 62(17-18):1653-7. PubMed ID: 9585152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of p33 gene expression by insulin and calcium ionophores.
    Weinstock RS; Manning CA; Messina JL
    Endocrinology; 1992 Feb; 130(2):616-24. PubMed ID: 1733711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
    Stoecklin G; Gross B; Ming XF; Moroni C
    Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.